Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01305473 · ClinicalTrials.gov registry record
A Retrospective Study With Prospective Follow-Up of Laparoscopic Ventral Hernia Repair Utilizing the Bard Sepramesh IP Composite
A clinical trial of Hernia, sponsored by C. R. Bard.
- Completed
- Registry status
- 90
- Enrollment target
- 1
- Study location
NCT01305473: Completed study of Hernia, sponsored by C. R. Bard.
NCT01305473 is a study of Hernia that has completed, run by C. R. Bard. The registered enrollment target is 90 participants, below the 195-participant average among 11 other Hernia trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01305473, a study of Hernia, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will enroll subjects who underwent a laparoscopic ventral hernia repair utilizing Sepramesh at least 12 months before starting in this study. The consented subjects' medical records will be reviewed for evidence of any risk factors of hernia recurrence, procedure time, complications and any documented recurrences. The subjects will be asked to undergo a physical exam to rule out any recurrences that were not documented in the medical records.
Primary Outcome
A recurrent hernia is a hernia, confirmed by the Investigator at any point after the surgery, in the same location as the hernia repaired in the index procedure.
Conditions Studied
Study Locations (1)
Ohio
- Cornerstone Medical Center - Centerville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-02 |
What the finished NCT01305473 record still lists
NCT01305473 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 195-participant average among 11 other Hernia trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Hernia appearing as the primary indexed condition, and to 0 interventions.
NCT01305473 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01305473 about?
NCT01305473 is a clinical study titled "A Retrospective Study With Prospective Follow-Up of Laparoscopic Ventral Hernia Repair Utilizing the Bard Sepramesh IP Composite". This study will enroll subjects who underwent a laparoscopic ventral hernia repair utilizing Sepramesh at least 12 months before starting in this study. The consented subjects' medical records will be reviewed for evidence of any risk factors of hernia recurrence, procedure time, complications and ...
What is the current status of trial NCT01305473?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2010-08. Estimated completion is 2011-02.
What conditions does trial NCT01305473 study?
This clinical trial studies the following conditions: Hernia.
Who is sponsoring clinical trial NCT01305473?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01305473 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01305473's enrollment target sits among peer trials
90 7th of 11 higher than 5 of 11 other Hernia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hernia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preoperative BOTOX® Injection for Large Ventral Hernia Repair
RECRUITING · Phase 4
-
Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH
RECRUITING · NA
-
Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia
ACTIVE NOT RECRUITING · NA
-
Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair
ACTIVE NOT RECRUITING · NA
-
Assess the Feasibility and Efficacy of the CollaRx® Bupivacaine Implant Laparoscopic Inguinal or Umbilical Herniorrhaphy
COMPLETED · Phase 2
-
Hernia Repair With or Without Sutures
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia